We found that the overexpression of DHX32 induced EMT in HCC cells, leading to increases in the expression of mesenchymal markers N-cadherin and vimentin and reduction in the expression of epithelial marker E-cadherin (Figure 2(B and C)). Here, DHX32 is linked to hepatocellular carcinoma.